Top Page
Ping An Healthcare and Technology Company
(1833)
Ping An Healthcare and Technology Company (1833) vs. iShares MSCI Hong Kong ETF (EWH)
Ping An Healthcare and Technology Company Business Overview & Revenue Model
Ping An Healthcare and Technology Company Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.22B | 4.81B | 4.67B | 6.21B | 7.33B | 6.87B |
| Gross Profit | 1.69B | 1.52B | 1.51B | 1.67B | 1.71B | 1.86B |
| EBITDA | 332.77M | 193.43M | -164.23M | -1.05B | -1.76B | -605.20M |
| Net Income | 158.94M | 81.43M | -322.59M | -636.06M | -1.54B | -948.48M |
Balance Sheet | ||||||
| Total Assets | 12.95B | 16.78B | 16.52B | 17.14B | 17.88B | 18.56B |
| Cash, Cash Equivalents and Short-Term Investments | 7.76B | 11.52B | 11.35B | 10.14B | 10.14B | 13.53B |
| Total Debt | 45.97M | 45.00M | 93.61M | 176.49M | 201.29M | 113.97M |
| Total Liabilities | 3.26B | 13.20B | 3.25B | 3.68B | 3.79B | 2.71B |
| Stockholders Equity | 9.70B | 3.59B | 13.28B | 13.46B | 14.08B | 15.83B |
Cash Flow | ||||||
| Free Cash Flow | 270.60M | 65.08M | -325.82M | -845.05M | -1.49B | -1.18B |
| Operating Cash Flow | 297.89M | 99.33M | -282.86M | -810.62M | -1.40B | -1.10B |
| Investing Cash Flow | 3.49B | 114.65M | -1.49B | 1.71B | -3.10B | -2.50B |
| Financing Cash Flow | -3.94B | -38.44M | -67.36M | -317.88M | -319.91M | 6.92B |
Ping An Healthcare and Technology Company Technical Analysis
Ping An Healthcare and Technology Company Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | HK$18.25B | 31.57 | 24.57% | 0.88% | 13.58% | 24.59% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | HK$344.40M | ― | -35.99% | ― | -5.38% | 63.93% | |
46 Neutral | HK$18.05B | ― | -15.75% | ― | 102.73% | 38.42% | |
45 Neutral | $35.10B | 168.29 | 1.37% | 33.36% | 14.56% | ― | |
45 Neutral | HK$5.21B | ― | -2.97% | ― | -12.31% | 41.72% | |
40 Neutral | HK$1.31B | ― | -12.97% | ― | -32.17% | -1.20% |
Ping An Healthcare and Technology Company Corporate Events
Ping An Healthcare and Technology Company Limited has announced a board meeting scheduled for August 19, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. The meeting will also consider the declaration and payment of an interim dividend, which could impact the company’s financial strategy and shareholder returns.
Ping An Healthcare and Technology Company Limited has announced the composition of its board of directors and their roles within the company. The announcement outlines the executive, non-executive, and independent non-executive directors, along with their participation in various board committees, which include the Audit and Risk Management Committee, Nomination and Remuneration Committee, and Sustainable Development Committee. This update is significant as it reflects the company’s governance structure and commitment to sustainable development, potentially impacting its strategic direction and stakeholder engagement.
Ping An Healthcare and Technology Company Limited announced the resignation of Mr. Jun Wu as an executive director and president, effective July 10, 2025, due to personal work arrangements. The company assures stakeholders that operations will remain unaffected and governance will continue to be efficient. Concurrently, Ms. Luoqi Zang has been appointed as an executive director. Ms. Zang, who joined the company in 2022, brings extensive experience in financial and operational management, having previously worked with prominent firms like PricewaterhouseCoopers and Didi Chuxing. Her appointment is expected to bolster the company’s strategic direction and operational oversight.
Ping An Healthcare and Technology Company Limited held its Annual General Meeting on June 26, 2025, where all proposed resolutions were approved by shareholders. Key resolutions included the adoption of the company’s audited financial statements, re-election of directors, and the appointment of Ernst & Young as the auditor. The meeting also granted the board mandates to issue and buy back shares, reflecting strong shareholder support and potentially impacting the company’s market operations and strategic flexibility.
Ping An Healthcare and Technology Company Limited has announced its upcoming annual general meeting scheduled for June 26, 2025, in Shanghai. Key agenda items include the adoption of the 2024 financial statements, re-election of directors, and appointment of Ernst & Young as the company’s auditor. The meeting will also consider resolutions to authorize the board to manage share allotments and related financial instruments, indicating a strategic focus on financial governance and operational continuity.
Ping An Healthcare and Technology Company Limited has announced a proposed change of auditor, with PricewaterhouseCoopers retiring after more than seven years of service. The company plans to appoint Ernst & Young as the new auditor, subject to shareholder approval at the upcoming annual general meeting. This change aims to maintain good corporate governance and ensure the independence and objectivity of the auditing process, aligning with the Corporate Governance Code and benefiting the company and its shareholders.